Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER J BETTACCHI

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1083669543
CMS profile
230546
Location
MARION, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$46,028.40

146 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER J BETTACCHI

NPI 1083669543 · CMS profile ID 230546

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

MARION, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083669543?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER J BETTACCHI, NPI 1083669543, CMS profile ID 230546. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083669543?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CHRISTOPHER J BETTACCHI, NPI 1083669543, CMS profile ID 230546. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083669543?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CHRISTOPHER J BETTACCHI, NPI 1083669543, CMS profile ID 230546, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1083669543?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

146 matching records · $46,028.40 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 146 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–146 of 146.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ViiV Healthcare Company $135.3403/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112741881 CMS
ViiV Healthcare Company $3,900.0003/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112781430 CMS
ABBVIE INC. $37.5303/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103318072 CMS
ViiV Healthcare Company $23.1103/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112718774 CMS
ViiV Healthcare Company $88.0003/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112726036 CMS
ViiV Healthcare Company $53.5503/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112750174 CMS
ViiV Healthcare Company $74.3403/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112767024 CMS
ViiV Healthcare Company $54.5103/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112822341 CMS
ViiV Healthcare Company $169.8603/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112773516 CMS
ViiV Healthcare Company $120.2703/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112785916 CMS
Gilead Sciences, Inc. $112.4303/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133821368 CMS
Merck Sharp & Dohme LLC $52.5103/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141812147 CMS
ViiV Healthcare Company $114.6903/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112720292 CMS
Ferring Pharmaceuticals Inc. $36.2803/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137464855 CMS
ViiV Healthcare Company $76.9102/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112750268 CMS
ViiV Healthcare Company $5.0002/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112790594 CMS
ViiV Healthcare Company $151.9702/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112807661 CMS
ViiV Healthcare Company $22.3102/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112773430 CMS
ViiV Healthcare Company $19.4702/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112705078 CMS
ViiV Healthcare Company $64.2902/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112714380 CMS
ViiV Healthcare Company $44.5202/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112754812 CMS
ViiV Healthcare Company $125.0002/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112769354 CMS
ViiV Healthcare Company $46.0502/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112800567 CMS
ViiV Healthcare Company $49.2002/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112821365 CMS
ViiV Healthcare Company $557.4402/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112721518 CMS
ViiV Healthcare Company $11.8202/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112794040 CMS
ViiV Healthcare Company $260.0002/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112801363 CMS
Insmed, Inc. $23.2302/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089574834 CMS
Merck Sharp & Dohme LLC $29.6002/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141900516 CMS
ViiV Healthcare Company $30.6402/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112727593 CMS
ViiV Healthcare Company $507.7202/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112748898 CMS
Napo Pharmaceuticals Inc $22.3002/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147971385 CMS
ViiV Healthcare Company $24.0002/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112701585 CMS
Gilead Sciences, Inc. $20.1102/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133821366 CMS
ViiV Healthcare Company $23.8501/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112823257 CMS
Insmed, Inc. $29.7701/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089578702 CMS
ViiV Healthcare Company $21.3901/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112745533 CMS
ABBVIE INC. $22.8001/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103318070 CMS
ViiV Healthcare Company $21.0401/17/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155884142 CMS
ViiV Healthcare Company $3,900.0001/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112824247 CMS
HOSPIRA, INC. $14.7801/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130967615 CMS
Shionogi Inc $14.8001/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154339110 CMS
Gilead Sciences, Inc. $17.7701/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133821364 CMS
Gilead Sciences, Inc. $22.1901/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133821362 CMS
ViiV Healthcare Company $21.8601/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1112806755 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.3701/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137487409 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,552.08 129
PY2020 $6,102.36 53
PY2021 $10,808.69 61
PY2022 $50,197.42 153
PY2023 $65,822.95 188
PY2024 $46,028.40 146
PY2025 $49,665.94 148

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $324,625.63 26
PY2024 Principal investigator $938,276.52 60
PY2023 Recipient $2,432.17 20
PY2023 Principal investigator $693,798.36 90
PY2022 Principal investigator $609,614.58 83
PY2021 Principal investigator $1,531,977.61 52
PY2020 Principal investigator $942,119.49 228
PY2019 Principal investigator $531,393.95 106

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $1,584.30 12/31/2025 Non-covered Recipient Entity
North Texas Infectious Diseases Consultants, P.A
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV No dispute reported 06/30/2026 1232933876
Principal investigator 1 ViiV Healthcare Company $21,488.25 11/19/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317241
Principal investigator 1 ABBVIE INC. $1,130.99 11/04/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202521077
Principal investigator 1 ViiV Healthcare Company $24,949.53 10/28/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319205
Principal investigator 1 ViiV Healthcare Company $16,297.36 09/23/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317239
Principal investigator 1 ViiV Healthcare Company $3,187.08 09/19/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317181
Principal investigator 1 ViiV Healthcare Company $7,334.74 08/29/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190319209
Principal investigator 1 ViiV Healthcare Company $32,732.88 08/15/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317237
Principal investigator 1 ABBVIE INC. $1,382.40 08/05/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202501142
Principal investigator 1 ViiV Healthcare Company $7,502.34 07/23/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317177
Principal investigator 1 ViiV Healthcare Company $25,220.75 07/17/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317229
Principal investigator 1 ViiV Healthcare Company $3,187.08 06/13/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317179
Principal investigator 1 ViiV Healthcare Company $23,270.46 06/13/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319207
Principal investigator 1 ViiV Healthcare Company $97,022.20 05/28/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317235
Principal investigator 1 ViiV Healthcare Company $12,970.04 05/19/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317175
Principal investigator 1 ViiV Healthcare Company $6,917.34 04/28/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190319213
Principal investigator 1 ViiV Healthcare Company $3,592.09 04/10/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317231
Principal investigator 1 ABBVIE INC. $2,076.64 04/03/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202472285
Principal investigator 1 ViiV Healthcare Company $6,052.71 03/21/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317173
Principal investigator 1 ViiV Healthcare Company $3,592.09 03/21/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317227
Principal investigator 1 ViiV Healthcare Company $2,733.14 03/21/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS PA
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317233
Principal investigator 1 ABBVIE INC. $1,148.18 03/07/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202461314
Principal investigator 1 ViiV Healthcare Company $9,561.24 02/24/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190319211
Principal investigator 1 ABBVIE INC. $1,722.27 02/06/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202448798
Principal investigator 1 ViiV Healthcare Company $6,154.79 01/08/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
A PHASE 2B MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY COMPARING THE EFF No dispute reported 06/30/2026 1190317171
Principal investigator 1 ABBVIE INC. $1,814.74 01/02/2025 Non-covered Recipient Entity
NORTH TEXAS INFECTIOUS DISEASES
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202435212